The clinical application of high-resolution peripheral computed tomography (HR-pQCT) in adults: state of the art and future directions.

Published on May 22, 2021in Osteoporosis International4.507
· DOI :10.1007/S00198-021-05999-Z
J. van den Bergh17
Estimated H-index: 17
(University of Hasselt),
Pawel Szulc54
Estimated H-index: 54
(University of Lyon)
+ 3 AuthorsRoland Chapurlat73
Estimated H-index: 73
(University of Lyon)
High-resolution peripheral computed tomography (HR-pQCT) was developed to image bone microarchitecture in vivo at peripheral skeletal sites. Since the introduction of HR-pQCT in 2005, clinical research to gain insight into pathophysiology of skeletal fragility and to improve prediction of fractures has grown. Meanwhile, the second-generation HR-pQCT device has been introduced, allowing novel applications such as hand joint imaging, assessment of subchondral bone and cartilage thickness in the knee, and distal radius fracture healing. This article provides an overview of the current clinical applications and guidance on interpretation of results, as well as future directions. Specifically, we provide an overview of (1) the differences and reference data for HR-pQCT variables by age, sex, and race/ethnicity; (2) fracture risk prediction using HR-pQCT; (3) the ability to monitor response of anti-osteoporosis therapy with HR-pQCT; (4) the use of HR-pQCT in patients with metabolic bone disorders and diseases leading to secondary osteoporosis; and (5) novel applications of HR-pQCT imaging. Finally, we summarize the status of the application of HR-pQCT in clinical practice and discuss future directions. From the clinical perspective, there are both challenges and opportunities for more widespread use of HR-pQCT. Assessment of bone microarchitecture by HR-pQCT improves fracture prediction in mostly normal or osteopenic elderly subjects beyond DXA of the hip, but the added value is marginal. The prospects of HR-pQCT in clinical practice need further study with respect to medication effects, metabolic bone disorders, rare bone diseases, and other applications such as hand joint imaging and fracture healing. The mostly unexplored potential may be the differentiation of patients with only moderately low BMD but severe microstructural deterioration, which would have important implications for the decision on therapeutical interventions.
đź“– Papers frequently viewed together
#1Danny Liew (Monash University)H-Index: 52
#2Roland Chapurlat (University of Lyon)H-Index: 73
Last. Ego Seeman (University of Melbourne)H-Index: 108
view all 6 authors...
OBJECTIVE Treatment is usually withheld from women with osteopenia even though they are the source of over 70% of all women having fragility fractures. As microstructural deterioration increases fracture risk and zoledronate reduces it, we aimed to determine whether identifying and treating women with osteopenia and severe microstructural deterioration is cost-effective. We also compared the health economic outcomes of 'global' versus 'targeted' treatment using SFS of women aged ≥70 years with o...
#1Sabashini K Ramchand (Harvard University)H-Index: 8
#2Natalie L David (Harvard University)H-Index: 3
Last. Joy N. Tsai (Harvard University)H-Index: 16
view all 7 authors...
In postmenopausal women at high risk of fracture, we previously reported that combined denosumab and high-dose (HD; 40 ÎĽg) teriparatide increased spine and hip bone mineral density (BMD) more than combination with standard-dose teriparatide (SD; 20 ÎĽg). To assess the effects of these combinations on bone microarchitecture and estimated bone strength, we performed high-resolution peripheral quantitative computed tomography (HR-pQCT) at the distal radius and distal tibia in these women, who were r...
#1Fan Yu (Peking Union Medical College Hospital)H-Index: 2
#2Yuping Xu (Peking Union Medical College Hospital)H-Index: 1
Last. Weibo Xia (Peking Union Medical College Hospital)H-Index: 22
view all 13 authors...
High-resolution peripheral quantitative computed tomography (HRpQCT) is an advanced 3D imaging technology that has the potential to contribute to fracture risk assessment and early diagnosis of osteoporosis. However, to date no studies have sought to establish normative reference ranges for HRpQCT measures among individuals from the Chinese mainland, significantly restricting its use. In this study, we collected HRpQCT scans from 863 healthy Chinese men and women aged 20 to 80 years using the la...
#1Danielle E. Whittier (U of C: University of Calgary)H-Index: 5
#2Lauren A Burt (U of C: University of Calgary)H-Index: 15
Last. Steven K. Boyd (U of C: University of Calgary)H-Index: 51
view all 4 authors...
There are currently no population-based reference data sets available for volumetric bone mineral density and microarchitecture parameters measured using the second-generation high-resolution peripheral quantitative computed tomography (HR-pQCT), yet the technology is rapidly becoming a standard for studies of bone microarchitecture. Although cross-calibrated data sets from the first-generation HR-pQCT have been reported, they are not suitable for second-generation bone microarchitecture propert...
#1Ada S Cheung (University of Melbourne)H-Index: 16
#2Rudolf Hoermann (University of Melbourne)H-Index: 31
Last. Mathis Grossmann (University of Melbourne)H-Index: 49
view all 10 authors...
Androgen deprivation therapy (ADT) given to men with prostate cancer causes rapid and severe sex steroid deficiency leading to increased bone remodeling and accelerated bone loss. To examine the effects of a single dose of zoledronic acid on bone microarchitecture we conducted a two year randomised placebo controlled trial in 76 men, mean age [IQR] 67.8 years [63.8;73.9] with non-metastatic prostate cancer commencing adjuvant ADT; 39 were randomised to zoledronic acid and 37 to matching placebo....
#1Karamjot Sidhu (U of C: University of Calgary)H-Index: 1
#2Steven K. Boyd (U of C: University of Calgary)H-Index: 51
Last. Aneal Khan (U of C: University of Calgary)H-Index: 14
view all 3 authors...
Abstract Gaucher disease (GD; OMIM 230800 ) is a lysosomal storage disorder caused by a deficiency in acid beta-glucosidase as a result of mutation in the GBA gene. Type 1 GD (GD1) is the most common form and its clinical manifestations include severe hematological, visceral and bone disease. The goal of disease-modifying treatments for GD1 is to reduce substrate storage and hence toxicity from the disease. The two common therapeutic routes for managing GD1 are enzyme replacement therapy (ERT) a...
#1Danielle E. Whittier (U of C: University of Calgary)H-Index: 5
#2Steven K. Boyd (U of C: University of Calgary)H-Index: 51
Last. Mary L. Bouxsein (Harvard University)H-Index: 107
view all 8 authors...
INTRODUCTION The application of high-resolution peripheral quantitative computed tomography (HR-pQCT) to assess bone microarchitecture has grown rapidly since its introduction in 2005. As the use of HR-pQCT for clinical research continues to grow, there is an urgent need to form a consensus on imaging and analysis methodologies so that studies can be appropriately compared. In addition, with the recent introduction of the second-generation HrpQCT, which differs from the first-generation HR-pQCT ...
#1Roland Chapurlat (University of Lyon)H-Index: 73
#2Minh Bui (University of Melbourne)H-Index: 22
Last. Ego Seeman (ACU: Australian Catholic University)H-Index: 108
view all 8 authors...
More than 70% of women sustaining fractures have osteopenia or "normal" bone mineral density (BMD). These women remain undetected using the BMD threshold of -2.5 SD for osteoporosis. As microstructural deterioration increases bone fragility disproportionate to the bone loss producing osteopenia/normal BMD, we hypothesized that the structural fragility score (SFS) of >/=70 units, a measure capturing severe cortical and trabecular deterioration, will identify these women. Distal radial images were...
#1Nicholas Mikolajewicz (McGill University)H-Index: 9
#2Nick Bishop (University of Sheffield)H-Index: 61
Last. Francis H. Glorieux (Shriners Hospitals for Children)H-Index: 97
view all 16 authors...
High-resolution peripheral quantitative computed tomography (HR-pQCT) is a noninvasive imaging modality for assessing volumetric bone mineral density (vBMD) and microarchitecture of cancellous and cortical bone. The objective was to (1) assess fracture-associated differences in HR-pQCT bone parameters; and (2) to determine if HR-pQCT is sufficiently precise to reliably detect these differences in individuals. We systematically identified 40 studies that used HR-pQCT (39/40 used XtremeCT scanners...
#1Kathryn S. Stok (University of Melbourne)H-Index: 23
#2Andrew J. Burghardt (UCSF: University of California, San Francisco)H-Index: 54
Last. Cheryl Barnabe (U of C: University of Calgary)H-Index: 29
view all 14 authors...
Background: Joint space assessment for rheumatoid arthritis (RA) by ordinal conventional radiographic scales is susceptible to floor and ceiling effects. High-resolution peripheral quantitative computed tomography (HR-pQCT) provides superior resolution, and may detect earlier changes. The goal of this work was to compare existing 3D methods to calculate joint space width (JSW) metrics in human metacarpophalangeal (MCP) joints with HR-pQCT and reach consensus for future studies. Using the consens...
Cited By1
#1Stuart J. Warden (IUPUI: Indiana University – Purdue University Indianapolis)H-Index: 57
#2Ziyue Liu (IUPUI: Indiana University – Purdue University Indianapolis)H-Index: 20
Last. Sharon M. Moe (IUPUI: Indiana University – Purdue University Indianapolis)H-Index: 70
view all 5 authors...
High-resolution peripheral quantitative computed tomography (HR-pQCT) is a powerful tool to assess bone health. To determine how an individual’s or population of interest’s HR-pQCT outcomes compare to expected, reference data are required. This study provides reference data for HR-pQCT measures acquired in a population of White adults. To provide age- and sex-specific reference data for high-resolution peripheral quantitative computed tomography (HR-pQCT) measures of the distal and diaphyseal ra...
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.